Last updated 7 days ago. Our resources are updated regularly but please keep in mind that links, programs, policies, and contact information do change.
The National Vaccine Injury Compensation Program (VICP) is a federal initiative offering a pathway for individuals who have experienced specific injuries following vaccination with certain covered vaccines to receive financial compensation.
Administered by the Health Resources & Services Administration (HRSA), the VICP operates as a “no-fault” system. This unique characteristic means that individuals seeking compensation are not required to prove that the vaccine manufacturer or the healthcare provider who administered the vaccine was negligent or at fault. Instead, the program focuses on whether the injury occurred and if it is causally linked to a covered vaccine.
By creating a more efficient and less adversarial compensation process, the VICP plays a vital role in ensuring a stable vaccine supply and maintaining public confidence in essential immunization programs.
History and Background
The creation of the VICP in 1986, through the National Childhood Vaccine Injury Act (NCVIA), marked a significant moment in addressing concerns surrounding vaccine safety and the stability of the vaccine market. This legislation emerged from a period of heightened public anxiety, particularly in the 1970s and 1980s, regarding the diphtheria, pertussis, and tetanus (DPT) vaccine.
Despite a lack of strong scientific evidence in many instances, the number of lawsuits against vaccine manufacturers surged, resulting in substantial financial payouts. This environment of increasing litigation and the associated financial risks led several major pharmaceutical companies to either halt vaccine production altogether or significantly increase prices to cover potential liability costs.
By the mid-1980s, the supply of critical vaccines was in jeopardy, raising serious fears among public health officials about the potential for widespread outbreaks of preventable diseases. In response to this looming crisis, Congress took decisive action by establishing the VICP.
The program was conceived as a carefully balanced solution, offering a “no-fault” mechanism to compensate individuals who might experience adverse effects from certain vaccines, while simultaneously providing a measure of liability protection to vaccine manufacturers and healthcare professionals who administer these vital immunizations.
The primary objectives of the VICP, as outlined in the National Childhood Vaccine Injury Act of 1986, were to:
- Ensure a consistent and adequate supply of vaccines by reducing the financial risks for manufacturers
- Stabilize the often-volatile costs of vaccines
- Create an accessible and efficient system for individuals who believe they have been injured by specific vaccines to receive compensation without the need for protracted and expensive traditional lawsuits
The Claims Process
The process of seeking compensation through the VICP begins with filing a petition (claim) with the U.S. Court of Federal Claims. This option is available to anyone, regardless of age, who believes they have been injured by a vaccine covered under the program. Parents, legal guardians, and legal representatives have the authority to file petitions on behalf of children, disabled adults, or individuals who have passed away.
Once a petition is submitted, it undergoes an initial review by the medical staff of the U.S. Department of Health and Human Services (HHS). This medical review is critical in determining whether the petitioner’s medical condition aligns with the established medical criteria for compensation related to the alleged vaccine injury. Following this assessment, HHS formulates a preliminary recommendation regarding the claim.
Subsequently, the U.S. Department of Justice (DOJ) takes over the process by developing a comprehensive report. This report integrates the medical recommendation provided by HHS with a detailed legal analysis of the case. Within the DOJ, attorneys from the Office of Vaccine Litigation, which is part of the Civil Division, play a crucial role in representing HHS throughout these proceedings, ensuring that fair compensation is awarded in cases that meet the program’s eligibility criteria.
The DOJ’s report is then presented to a special master, who is appointed by the U.S. Court of Federal Claims. These special masters function similarly to judges in the VICP system. They carefully review all the evidence presented, often conduct hearings where both the petitioner and the government have the opportunity to present their arguments and supporting evidence, and ultimately make a decision on whether the petitioner is entitled to compensation.
If the special master concludes that the petitioner is eligible for compensation, they will issue an order directing HHS to award the appropriate amount and type of compensation.
A notable feature of the VICP is the provision regarding attorneys’ fees and costs. Even in situations where a petition is ultimately dismissed, the Court has the discretion to order HHS to cover the petitioner’s reasonable attorneys’ fees and costs, provided that the petition was filed in good faith and had a reasonable basis. This provision helps ensure that individuals have access to legal representation without facing prohibitive financial burdens, even if their claim is not successful.
While the VICP is designed to be the primary route for resolving vaccine injury claims, petitioners who disagree with the special master’s final judgment retain the option to reject the decision or withdraw their petition within a specific timeframe and pursue a lawsuit in state or federal court against the vaccine manufacturer and/or the healthcare provider who administered the vaccine. However, the NCVIA includes certain provisions that make such lawsuits more challenging to win, and as a result, relatively few have been filed since the VICP’s inception.
For added convenience, individuals who have already filed a petition with the court can electronically submit a copy through the HRSA Injury Compensation Programs portal.
Eligibility Requirements
Eligibility for filing a claim with the VICP is broadly defined to include any individual, irrespective of age, who has received a vaccine covered by the program and believes they have sustained an injury as a result. This inclusive approach ensures that vaccine-related injuries occurring at any stage of life can be considered for compensation.
The VICP recognizes that individuals who may have experienced a vaccine injury might not always be able to navigate the claims process themselves. Therefore, the program allows parents to file petitions on behalf of their children, legal guardians to file for disabled adults under their care, and legal representatives to file on behalf of individuals who have passed away.
To be eligible for compensation under the VICP, several key requirements must be met:
- The individual must have received a covered vaccine (see Section V for details)
- The individual must have suffered an eligible vaccine injury. Generally, this means that the injury must have:
- Persisted for more than six months from the date of vaccination
- Required inpatient hospitalization and surgical intervention, or
- Resulted in death
- The claim must be filed within specific time limits (detailed in Section VI):
- For injuries where the affected person is still living: within three years from the onset of the first symptom
- For death cases: within two years of the date of death, provided that the death occurred within four years of the first symptom of the injury
These eligibility criteria ensure that the program provides recourse for individuals who have genuinely experienced adverse effects from covered vaccines while also establishing clear parameters for what constitutes a compensable injury and ensuring that claims are filed in a timely manner.
Covered Vaccines
The cornerstone for determining which vaccines are covered under the VICP is the Vaccine Injury Table, maintained by the U.S. Health Resources and Services Administration (HRSA). This table not only lists the vaccines covered by the program but also specifies certain injuries that are presumed to be caused by those vaccines if they manifest within a particular timeframe after vaccination.
As of the latest information, the vaccines included on the Vaccine Injury Table offer protection against a range of diseases:
Covered Vaccines Under the VICP
- Diphtheria
- Tetanus
- Pertussis (whooping cough)
- Measles
- Mumps
- Rubella (German measles)
- Polio
- Hepatitis A
- Hepatitis B
- Varicella (chickenpox)
- Haemophilus influenzae type b (Hib)
- Rotavirus
- Pneumococcal conjugate
- Seasonal influenza
Beyond the vaccines explicitly listed on the table, the VICP also extends its coverage to include “[a]ny new vaccine recommended by the Centers for Disease Control and Prevention for routine administration to children and/or pregnant women, after publication by the Secretary of a notice of coverage”. This provision ensures that the program remains adaptable and responsive to evolving public health recommendations and the introduction of new vaccines.
It is critically important to note that, at present, vaccines developed for COVID-19 are not covered under the VICP. Individuals who believe they have experienced an injury as a result of a COVID-19 vaccine should instead seek information and file claims through the Countermeasures Injury Compensation Program (CICP).
Injury Table and Filing Deadlines
The Vaccine Injury Table serves as a crucial component of the VICP by outlining specific injuries that, when occurring within a designated time after the administration of a covered vaccine, are presumed to be caused by that vaccine. This presumption of causation can significantly streamline the compensation process for individuals whose injuries and timelines align with the information provided in the table.
However, the VICP also recognizes that not all vaccine-related adverse events may be listed on the table, or that the onset of an injury might occur outside the specified timeframe. In such instances, individuals still have the option to file a petition with the VICP. These are often referred to as “off-table” injuries.
In cases involving off-table injuries, the responsibility of demonstrating a direct causal link between the vaccination and the injury rests with the claimant. This typically requires the presentation of comprehensive medical evidence, including detailed medical records and potentially expert testimony from medical professionals.
It is imperative for anyone considering filing a claim with the VICP to be aware of the strict time limits that have been established for submitting petitions. Failure to adhere to these deadlines will likely result in the denial of the claim. The specific timeframes for filing are as follows:
Time Limits for Filing VICP Claims
- Non-Fatal Injury Claims: Must be filed within 3 years after the first symptom or manifestation of onset or of the significant aggravation of the injury
- Death Claims: Must be filed within 2 years of the death and within 4 years of the first symptom of the injury from which the death resulted
These time limits underscore the importance of taking prompt action if an individual believes they have experienced an adverse event following vaccination with a covered vaccine. Gathering relevant medical documentation and seeking legal counsel, if needed, in a timely manner is essential to ensure the best possible outcome for a potential claim.
Types of Compensation Available
Individuals whose petitions are deemed compensable under the VICP may be eligible to receive various forms of financial assistance to address the impacts of their vaccine-related injury. This includes:
- Compensation for expenses related to medical care and rehabilitation, covering both past and anticipated future costs associated with treating the injury
- Compensation for pain and suffering, although this is subject to a statutory cap of $250,000
- Compensation for lost earnings, both past and future, for individuals who have experienced a loss of income due to their inability to work as a result of their vaccine injury
In the tragic event that a covered vaccine results in the death of an individual, the VICP offers a death benefit to surviving family members, which is also capped at $250,000.
A unique and significant aspect of the VICP is the provision for the payment of attorneys’ fees and costs. The program will separately cover the reasonable legal expenses incurred by individuals in filing a claim, even if the claim is ultimately not successful, provided that the petition was filed in good faith and had a reasonable basis. This feature of the VICP is intended to ensure that individuals have access to legal representation to navigate the complexities of the program without facing an additional financial burden.
The “No-Fault” Nature of VICP
A fundamental characteristic of the VICP is its designation as a “no-fault” system. This is a critical distinction from traditional legal avenues for seeking compensation for injuries. In typical personal injury lawsuits, the plaintiff must demonstrate that the defendant was negligent or otherwise at fault in causing the injury. However, under the VICP, petitioners are not required to prove any fault or negligence on the part of the vaccine manufacturer or the healthcare provider who administered the vaccine.
Instead, the primary focus of the VICP process is on establishing whether a covered vaccine caused the alleged injury. This “no-fault” approach leads to a more streamlined and less adversarial process for resolving vaccine injury claims compared to the often lengthy, expensive, and emotionally challenging experience of traditional litigation in the civil court system.
The “no-fault” nature of the VICP offers significant benefits to claimants by potentially making it easier to receive compensation for legitimate vaccine injuries without the need to meet the often-high legal threshold of proving negligence. Furthermore, the program’s provision for covering attorneys’ fees helps to reduce the financial risks associated with pursuing a claim.
From the perspective of the vaccine industry, the establishment of the VICP was also intended to provide a degree of liability protection for vaccine manufacturers and healthcare providers. This liability protection was a key factor in stabilizing the vaccine market and ensuring a consistent supply of these essential public health tools. By creating a dedicated compensation program for vaccine-related injuries, the government aimed to mitigate the risk of unpredictable and potentially crippling lawsuits against the vaccine industry, thereby encouraging continued investment in vaccine development and production.
VICP vs. CICP: Understanding the Difference
It is important to differentiate the VICP from other federal programs that provide compensation for injuries, particularly the Countermeasures Injury Compensation Program (CICP). While both programs are administered by the Health Resources & Services Administration (HRSA), they are designed to address different types of medical interventions.
The CICP was established to provide benefits to individuals who experience serious injuries or death as a direct result of the administration or use of a covered countermeasure. These countermeasures are typically used to prevent, diagnose, or treat certain diseases, health conditions, or security threats that constitute a public health emergency.
The most significant distinction between the VICP and the CICP lies in the scope of medical products they cover:
- The VICP primarily provides compensation for injuries resulting from vaccines that are routinely recommended for children (and some vaccines for pregnant women), as specified on the Vaccine Injury Table
- The CICP has a broader scope and covers a range of countermeasures, which can include vaccines, medications, devices, or other substances used during public health emergencies, such as the response to the COVID-19 pandemic
Currently, vaccines for COVID-19 are covered under the CICP, and not under the VICP. Individuals who believe they have been injured by a COVID-19 vaccine or another covered countermeasure should seek information and file a Request for Benefits with the CICP. The CICP can be contacted by phone at 1-855-266-2427, and further information is available on their website.
Resources for More Information
For individuals seeking more information about the VICP or looking to file a claim, a variety of resources are available:
- Official HRSA Website for VICP
- About the Program
- Covered Vaccines
- Who Can File a Petition?
- How to File a Petition
- Vaccine Injury Compensation Data
- Frequently Asked Questions (FAQ)
- Resources (fact sheets and booklets)
- Vaccine Injury Table
Contact Information
- Toll-Free Phone Number: 1-800-338-2382
- Email Address: [email protected]
- U.S. Court of Federal Claims: Visit their website or call (202) 357-6400 for information on filing rules
Our articles make government information more accessible. Please consult a qualified professional for financial, legal, or health advice specific to your circumstances.